Pathology Workbench

Trials

135 participants · First posted Apr 2, 2019

Unknown

NCT01569555

Significant Pathology Associated With Crossed Leg Sign

400 participants · First posted Apr 3, 2012

Recruiting

NCT07157618

Prospective Pathology Foundation Models

2,000 participants · First posted Sep 5, 2025

Drugs

View all 4 →

Cardiometabolic pathology(Octagon Therapeutics/ Novo Nordisk)

Haemophilia B gene therapy(Sir William Dunn School of Pathology)

Biotech

Approved

Lecanemab(Leqembi)

Manufacturer: Biogen

Conditions: Alzheimer's Disease (AD)

Rx

Organizations

View all 13 →

Speech Pathology & Audiology

United States

NSW HEALTH PATHOLOGY

Australia

Molecular Pathology Laboratory Network, Inc.

United States

News

View all 1180 →

last year

Belay Diagnostics and GenomOncology Partner to Enhance CNS Cancer Liquid Biopsy Testing

last year

GenomOncology and Chronetyx Laboratories Partner to Accelerate Cancer Treatment Through Advanced Genomic Testing

last year

Trials

Mineral Nano Pathology

Significant Pathology Associated With Crossed Leg Sign

Prospective Pathology Foundation Models

Drugs

Cardiometabolic pathology(Octagon Therapeutics/ Novo Nordisk)

Haemophilia B gene therapy(Sir William Dunn School of Pathology)

Lecanemab(Leqembi)

Organizations

Speech Pathology & Audiology

NSW HEALTH PATHOLOGY

Molecular Pathology Laboratory Network, Inc.

News

Belay Diagnostics and GenomOncology Partner to Enhance CNS Cancer Liquid Biopsy Testing

GenomOncology and Chronetyx Laboratories Partner to Accelerate Cancer Treatment Through Advanced Genomic Testing

FDA Clears Epredia's E1000 Dx Digital Pathology Solution for Cancer Diagnostics